Prevalence and predictors of off-label use of cardiac resynchronization therapy in patients enrolled in the National Cardiovascular Data Registry Implantable Cardiac-Defibrillator Registry.
OBJECTIVE
The purpose of the study was to define the extent and nature of cardiac resynchronization therapy (CRT) device usage outside consensus guidelines using national data.


BACKGROUND
Recent literature has shown that the application of CRT in clinical practice frequently does not adhere to evidence-based consensus guidelines. Factors underlying these practices have not been fully explored.


METHODS
From the National Cardiovascular Data Registry's Implantable Cardiac-Defibrillator Registry, we defined a cohort of 45,392 cardiac resynchronization therapy-defibrillator (CRT-D) implants between January 2006 and June 2008 with a primary prevention indication. We defined "off-label" implants as those in which the ejection fraction was >35%, the New York Heart Association functional class was below III, or the QRS interval duration was <120 ms in the absence of a documented need for ventricular pacing. The relationships between patient, implanting physician, and hospital characteristics with off-label use were explored with multivariable hierarchical logistic regression models.


RESULTS
Overall, 23.7% of devices were placed without meeting all 3 implant criteria, most often due to New York Heart Association functional class below III (13.1% of implants) or QRS interval duration <120 ms (12.0%). Atrial fibrillation/flutter, previous percutaneous coronary intervention, and the performance of an electrophysiology study before implant were independently associated with increased odds of off-label use, whereas diabetes mellitus, increasing age, and female sex were associated with decreased odds. Physician training and insurance payer were weakly associated with the likelihood of off-label use.


CONCLUSIONS
Nearly 1 in 4 patients receiving CRT devices in the study time frame did not meet guideline-based indications. Given the evolving evidence base supporting the use of CRT, these practices require careful scrutiny.
Fein
Adam S
AS
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Wang
Yongfei
Y
Curtis
Jeptha P
JP
Masoudi
Frederick A
FA
Varosy
Paul D
PD
Reynolds
Matthew R
MR
D000368:Aged; D002304:Cardiac Pacing, Artificial / Q000706:statistics & numerical data*; D017147:Defibrillators, Implantable / Q000706:statistics & numerical data; D005260:Female; D019983:Guideline Adherence; D006801:Humans; D008297:Male; D017410:Practice Guidelines as Topic; D012042:Registries; D014481:United States
Circulation. 2008 May 20;117(20):2608-16
18458170
J Am Coll Cardiol. 2006 Aug 15;48(4):734-43
16904542
J Am Coll Cardiol. 2010 Feb 23;55(8):774-82
20170816
JAMA. 2009 Apr 22;301(16):1661-70
19383957
Circulation. 2008 Aug 26;118(9):926-33
18697821
J Am Coll Cardiol. 2006 Dec 5;48(11):2251-7
17161255
J Cardiovasc Electrophysiol. 2005 Nov;16(11):1160-5
16302897
Heart Rhythm. 2008 Sep;5(9):1359-63
18774117
N Engl J Med. 2004 May 20;350(21):2140-50
15152059
Circulation. 2009 Nov 10;120(19):1858-65
19858419
N Engl J Med. 2005 Apr 14;352(15):1539-49
15753115
Eur Heart J. 2008 Jul;29(13):1644-52
18390869
J Am Coll Cardiol. 2006 Dec 5;48(11):2243-50
17161254
Eur J Heart Fail. 2001 Aug;3(4):481-9
11511435
J Am Coll Cardiol. 2003 Dec 17;42(12):2117-24
14680737
J Am Coll Cardiol. 2009 Nov 10;54(20):1837-46
19800193
N Engl J Med. 2007 Dec 13;357(24):2461-71
17986493
J Gen Intern Med. 2008 Jan;23 Suppl 1:13-9
18095038
JAMA. 2002 Dec 25;288(24):3115-23
12495391
J Am Coll Cardiol. 2008 Jan 22;51(3):288-96
18206738
J Am Coll Cardiol. 2005 Sep 20;46(6):e1-82
16168273
N Engl J Med. 2002 Jun 13;346(24):1845-53
12063368
Circulation. 2006 Jan 24;113(3):374-9
16432068
Heart Rhythm. 2009 Mar;6(3):325-31
19251206
J Am Coll Cardiol. 2008 May 27;51(21):e1-62
18498951
N Engl J Med. 2009 Oct 1;361(14):1329-38
19723701
J Am Coll Cardiol. 2009 Apr 14;53(15):e1-e90
19358937
Circ Arrhythm Electrophysiol. 2008 Oct;1(4):240-9
19169382
Circ Cardiovasc Qual Outcomes. 2010 Mar;3(2):204-11
20197509